2021
DOI: 10.3923/pjbs.2021.1169.1174
|View full text |Cite
|
Sign up to set email alerts
|

Seroprevalence of Toxoplasma gondii, Rubella, Group A Streptococcus, CMV and HSV-1 in COVID-19 Patients with Vitamin D Deficiency

Abstract: Background and Objective: In recent years, respiratory tract viral infections have caused many pandemics that impact the whole world.To investigate the seropositivity of Toxoplasma gondii, rubella, CMV, HSV-1 and group A Streptococcus in recovered COVID-19 patients and correlate these findings with vitamin D levels. Materials and Methods: A total of 417 COVID-19 patients with diarrhoea were enrolled in this study. Vitamin D and seroprevalence for Toxoplasma gondii, rubella, CMV, HSV-1 and group A Streptococcus… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2023
2023
2025
2025

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 15 publications
0
4
0
Order By: Relevance
“…In contrast, Geraili et al reported a prevalence rate of 26.1% in northern Iran (15). In Saudi Arabia, Halawi M. et al reported that 64.3% of patients with COVID-19 had toxoplasmosis (14). On the other hand, a similar study proposed by Galván-Ramírez MdlL.…”
Section: Discussionmentioning
confidence: 89%
See 3 more Smart Citations
“…In contrast, Geraili et al reported a prevalence rate of 26.1% in northern Iran (15). In Saudi Arabia, Halawi M. et al reported that 64.3% of patients with COVID-19 had toxoplasmosis (14). On the other hand, a similar study proposed by Galván-Ramírez MdlL.…”
Section: Discussionmentioning
confidence: 89%
“…The frequency of exposure to T. gondii, detected through the presence of IgG in patients with COVID-19, reached 49% (95% CI: 34-63%; 2,947 participants; 13 studies; I 2 = 98%, p < 0.01) (Fig. 2) (11)(12)(13)(14)(15)(16)(17)(18)(19)(20)(21)(22)(23). In addition, the frequency of exposure to T. gondii, detected through the presence of IgM in patients with COVID-19, reached 2% (95% CI: 0-6%; 1,302 participants; 6 studies; I 2 = 94%, p < 0.01) (Fig.…”
Section: Quality Of the Included Studies And Publication Biasmentioning
confidence: 97%
See 2 more Smart Citations